Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 3/2008

01-03-2008 | Article

Campylobacter fetus bloodstream infection: risk factors and clinical features

Authors: L. Gazaigne, P. Legrand, B. Renaud, B. Bourra, E. Taillandier, C. Brun-Buisson, P. Lesprit

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 3/2008

Login to get access

Abstract

In this paper, we report 21 cases of Campylobacter fetus bloodstream infection observed in our institution over a 9-year period. The median age of the patients was 78 years. Most of them (62%) had a significant underlying disease, such as diabetes, immunodeficiency or cardiovascular disease. The main clinical features were fever with (62% of cases) or without (38%) extra-intestinal symptoms. These included mycotic aneurysm of the abdominal aorta (24%) and cellulitis (19%). Antibiotic treatment was mainly based on amoxicilline-clavulanate (57%) or imipenem (21%), for a median duration of 28 days. A favourable outcome was observed in 72% of cases. Death directly attributable to infection was observed for three patients, due to the rupture of an infected aneurysm or relapsing bloodstream infection with septic shock. All patients initially treated with imipenem had a favourable outcome. This report adds evidence that C. fetus bloodstream infection should be suspected in elderly patients with fever, immunodeficiency and cardiovascular damages. Imipenem seems to be the most active drug, especially in severe cases.
Literature
1.
go back to reference Ichiyama S, Hirai S, Minami T, Nishiyama Y, Shimizu S, Shimokata K, Ohta M (1998) Campylobacter fetus subspecies fetus cellulitis associated with bacteremia in debilitated hosts. Clin Infect Dis 27:252–255PubMedCrossRef Ichiyama S, Hirai S, Minami T, Nishiyama Y, Shimizu S, Shimokata K, Ohta M (1998) Campylobacter fetus subspecies fetus cellulitis associated with bacteremia in debilitated hosts. Clin Infect Dis 27:252–255PubMedCrossRef
2.
go back to reference Francioli P, Herzstein J, Grob JP, Vallotton JJ, Mombelli G, Glauser MP (1985) Campylobacter fetus subspecies fetus bacteremia. Arch Intern Med 145:289–292PubMedCrossRef Francioli P, Herzstein J, Grob JP, Vallotton JJ, Mombelli G, Glauser MP (1985) Campylobacter fetus subspecies fetus bacteremia. Arch Intern Med 145:289–292PubMedCrossRef
3.
go back to reference Morrison VA, Lloyd BK, Chia JKS, Tuazon CU (1990) Cardiovascular and bacteremic manifestations of Campylobacter fetus infection: case report and review. Rev Infect Dis 12:387–392PubMed Morrison VA, Lloyd BK, Chia JKS, Tuazon CU (1990) Cardiovascular and bacteremic manifestations of Campylobacter fetus infection: case report and review. Rev Infect Dis 12:387–392PubMed
4.
go back to reference Uwe S, Chmel H, Kaminski Z, Sen P (1980) The clinical spectrum of Campylobacter fetus infections: report of five cases and review of the literature. Q J Med 196:431–442 Uwe S, Chmel H, Kaminski Z, Sen P (1980) The clinical spectrum of Campylobacter fetus infections: report of five cases and review of the literature. Q J Med 196:431–442
5.
go back to reference Kanj SS, Araj GK, Taher A, Reller LB (2001) Campylobacter fetus pericarditis in a patient with beta-thalassemia: case report and review of the literature. Clin Microb Infect 7:510–513CrossRef Kanj SS, Araj GK, Taher A, Reller LB (2001) Campylobacter fetus pericarditis in a patient with beta-thalassemia: case report and review of the literature. Clin Microb Infect 7:510–513CrossRef
6.
go back to reference Lozano P, Rimbau EM, Martínez S, Ribas MA, Gómez FT (1999) Campylobacter fetus infection of a previously excluded popliteal aneurysm. Eur J Vasc Endovasc Surg 18:86–88PubMedCrossRef Lozano P, Rimbau EM, Martínez S, Ribas MA, Gómez FT (1999) Campylobacter fetus infection of a previously excluded popliteal aneurysm. Eur J Vasc Endovasc Surg 18:86–88PubMedCrossRef
7.
go back to reference Peetermans WE, De Man F, Moerman P, van de Werf F (2000) Fatal prosthetic valve endocarditis due to Campylobacter fetus. Inf Soc 41:180–182 Peetermans WE, De Man F, Moerman P, van de Werf F (2000) Fatal prosthetic valve endocarditis due to Campylobacter fetus. Inf Soc 41:180–182
8.
go back to reference Rutherford EJ, Eakins JW, Maxwell JG, Tackett AD (1989) Abdominal aortic aneurysm infected with Campylobacter fetus subspecies fetus. J Vasc Surg 10:193–197PubMedCrossRef Rutherford EJ, Eakins JW, Maxwell JG, Tackett AD (1989) Abdominal aortic aneurysm infected with Campylobacter fetus subspecies fetus. J Vasc Surg 10:193–197PubMedCrossRef
9.
go back to reference Bosshard PP, Kronenberg A, Zbinden R, Ruef C, Böttger EC, Altwegg M (2003) Etiologic diagnosis of infective endocarditis by broad-range polymerase chain reaction: a 3-year experience. Clin Infect Dis 37:167–172PubMedCrossRef Bosshard PP, Kronenberg A, Zbinden R, Ruef C, Böttger EC, Altwegg M (2003) Etiologic diagnosis of infective endocarditis by broad-range polymerase chain reaction: a 3-year experience. Clin Infect Dis 37:167–172PubMedCrossRef
10.
go back to reference Comité de l’Antibiogramme de la Société Française de Microbiologie (2003) Report 2003. Int J Antimicrob Agents 21:364–391CrossRef Comité de l’Antibiogramme de la Société Française de Microbiologie (2003) Report 2003. Int J Antimicrob Agents 21:364–391CrossRef
11.
go back to reference Tremblay C, Gaudreau C, Lorange M (2003) Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp.fetus strains isolated in Québec, Canada, from 1983 to 2000. J Clin Microbiol 41:463–466PubMedCrossRef Tremblay C, Gaudreau C, Lorange M (2003) Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp.fetus strains isolated in Québec, Canada, from 1983 to 2000. J Clin Microbiol 41:463–466PubMedCrossRef
12.
go back to reference Pigraud C, Bartolome R, Almirante B, Planes A, Gavalda J, Pahissa A (1997) Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns. Clin Infect Dis 25:1414–1420CrossRef Pigraud C, Bartolome R, Almirante B, Planes A, Gavalda J, Pahissa A (1997) Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns. Clin Infect Dis 25:1414–1420CrossRef
13.
go back to reference Spelman DW, Davidson N, Buckmaster ND, Spicer WJ, Ryan P (1986) Campylobacter bacteraemia: a report of 10 cases. Med J Austr 145:503–505 Spelman DW, Davidson N, Buckmaster ND, Spicer WJ, Ryan P (1986) Campylobacter bacteraemia: a report of 10 cases. Med J Austr 145:503–505
14.
go back to reference Hervé J, Aissa N, Legrand P, Sorkine M, Calmette MJ, Santín A, Roupie E, Renaud B (2004) Campylobacter fetus meningitis in a diabetic adult cured by imipenem. Eur J Clin Microbiol Infect Dis 23:722–724PubMedCrossRef Hervé J, Aissa N, Legrand P, Sorkine M, Calmette MJ, Santín A, Roupie E, Renaud B (2004) Campylobacter fetus meningitis in a diabetic adult cured by imipenem. Eur J Clin Microbiol Infect Dis 23:722–724PubMedCrossRef
15.
go back to reference Anolik JR, Mildvan D, Winter JW, Puttlitz D, Rubenstein S, Lozman H (1983) Mycotic aortic aneurysm. A complication of Campylobacter fetus septicemia. Arch Intern Med 143:609–610PubMedCrossRef Anolik JR, Mildvan D, Winter JW, Puttlitz D, Rubenstein S, Lozman H (1983) Mycotic aortic aneurysm. A complication of Campylobacter fetus septicemia. Arch Intern Med 143:609–610PubMedCrossRef
16.
go back to reference Farrugia DC, Eykyn SJ, Smyth EG (1994) Campylobacter fetus endocarditis: two case reports and review. Clin Infect Dis 18:443–446PubMed Farrugia DC, Eykyn SJ, Smyth EG (1994) Campylobacter fetus endocarditis: two case reports and review. Clin Infect Dis 18:443–446PubMed
17.
go back to reference Miki K, Maekura R, Hiraga T, Hirotani A, Hashimoto H, Kitada S, Miki M, Yoshimura K, Naka N, Motone M, Fujikawa T, Takashima S, Kitazume R, Kanzaki H, Nakatani S, Watanuki H, Tagusari O, Kobayashi J, Ito M (2005) Infective tricuspid valve endocarditis with pulmonary emboli caused by Campylobacter fetus after tooth extraction. Intern Med 44:1055–1059PubMedCrossRef Miki K, Maekura R, Hiraga T, Hirotani A, Hashimoto H, Kitada S, Miki M, Yoshimura K, Naka N, Motone M, Fujikawa T, Takashima S, Kitazume R, Kanzaki H, Nakatani S, Watanuki H, Tagusari O, Kobayashi J, Ito M (2005) Infective tricuspid valve endocarditis with pulmonary emboli caused by Campylobacter fetus after tooth extraction. Intern Med 44:1055–1059PubMedCrossRef
18.
go back to reference Righter J, Woods JM (1985) Campylobacter and endovascular lesions. Can J Surg 28:451–452PubMed Righter J, Woods JM (1985) Campylobacter and endovascular lesions. Can J Surg 28:451–452PubMed
19.
go back to reference Teh HS, Chiang SH, Tan AGS, Sng LH, Oh HML (2004) A case of right loin pain: septic ovarian vein thrombosis due to Campylobacter fetus bacteraemia. Ann Acad Med Singapore 33:385–388PubMed Teh HS, Chiang SH, Tan AGS, Sng LH, Oh HML (2004) A case of right loin pain: septic ovarian vein thrombosis due to Campylobacter fetus bacteraemia. Ann Acad Med Singapore 33:385–388PubMed
20.
go back to reference Montero A, Corbella X, López JA, Santín M, Ballón IH (1997) Campylobacter fetus-associated aneurysms: report of a case involving the popliteal artery and review of the literature. Clin Infect Dis 24:1019–1021PubMed Montero A, Corbella X, López JA, Santín M, Ballón IH (1997) Campylobacter fetus-associated aneurysms: report of a case involving the popliteal artery and review of the literature. Clin Infect Dis 24:1019–1021PubMed
21.
go back to reference Briedis DJ, Khamessan A, McLaughlin RW, Vali H, Panaritou M, Chan ECS (2002) Isolation of Campylobacter fetus subsp. fetus from a patient with cellulitis. J Clin Microbiol 40:4792–4796PubMedCrossRef Briedis DJ, Khamessan A, McLaughlin RW, Vali H, Panaritou M, Chan ECS (2002) Isolation of Campylobacter fetus subsp. fetus from a patient with cellulitis. J Clin Microbiol 40:4792–4796PubMedCrossRef
22.
go back to reference Tremblay C, Gaudreau C (1998) Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus. Antimicrob Agents Chemother 42:1847–1849PubMed Tremblay C, Gaudreau C (1998) Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus. Antimicrob Agents Chemother 42:1847–1849PubMed
23.
go back to reference Blaser MJ, Allos BM (2005) Campylobacter jejuni and related species. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and practice of infectious diseases, 6th edn. Churchill Livingstone, Philadelphia, Pennsylvania, pp 2548–2556 Blaser MJ, Allos BM (2005) Campylobacter jejuni and related species. In: Mandell GL, Bennett JE, Dolin R (eds) Principles and practice of infectious diseases, 6th edn. Churchill Livingstone, Philadelphia, Pennsylvania, pp 2548–2556
Metadata
Title
Campylobacter fetus bloodstream infection: risk factors and clinical features
Authors
L. Gazaigne
P. Legrand
B. Renaud
B. Bourra
E. Taillandier
C. Brun-Buisson
P. Lesprit
Publication date
01-03-2008
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 3/2008
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-007-0415-0

Other articles of this Issue 3/2008

European Journal of Clinical Microbiology & Infectious Diseases 3/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.